Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$407K Sell
3,387
-6,426
-65% -$742K 0.14% 159
2025
Q4
$1.03M Sell
9,813
-2,019
-17% -$190K 0.36% 69
2025
Q3
$995K Sell
11,832
-8,770
-43% -$722K 0.39% 61
2025
Q2
$1.85M Hold
20,602
0.87% 29
2025
Q1
$1.85M Buy
20,602
+1,820
+10% +$170K 0.87% 29
2024
Q4
$1.87M Buy
18,782
+1,159
+7% +$119K 0.82% 31
2024
Q3
$2M Buy
17,623
+1,801
+11% +$214K 0.91% 28
2024
Q2
$1.96M Buy
15,822
+701
+5% +$90.3K 0.93% 29
2024
Q1
$2M Buy
15,121
+1,832
+14% +$226K 0.95% 28
2023
Q4
$1.45M Buy
+13,289
New +$1.38M 0.73% 33
2023
Q3
Sell
-12,903
Closed -$1.49M 149
2023
Q2
$1.49M Sell
12,903
-369
-3% -$41.9K 0.8% 31
2023
Q1
$1.41M Buy
13,272
+3,742
+39% +$404K 0.8% 33
2022
Q4
$1.05M Sell
9,530
-44
-0.5% -$4.5K 0.6% 50
2022
Q3
$846K Buy
9,574
+242
+3% +$21.6K 0.52% 54
2022
Q2
$851K Buy
9,332
+531
+6% +$47.1K 0.52% 55
2022
Q1
$722K Buy
8,801
+722
+9% +$56.9K 0.38% 63
2021
Q4
$660K Buy
+8,079
New +$643K 0.37% 61

Other funds holding MRK

Saxon Interests's MRK Position: Q1 2026 in Review

Saxon Interests reduced its Merck (MRK) stake by 65% in Q1 2026, selling an estimated $742K and leaving 3,387 shares worth $407K. The position accounts for 0.14% of the portfolio, ranked #159.

Saxon Interests first reported a position in MRK in Q4 2021 and has held it in 17 quarters since. The position peaked at $2M in Q3 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Saxon Interests held 3,387 shares of Merck worth $407K as of Q1 2026.
  • Saxon Interests sold 6,426 Merck shares in Q1 2026, an estimated $742K.
  • Merck made up 0.14% of Saxon Interests's portfolio in Q1 2026, its #159 holding.
  • Saxon Interests first reported a position in Merck in Q4 2021 and has held it in 17 quarters since.
  • Saxon Interests's Merck position peaked at $2M in Q3 2024.
  • 3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Saxon Interests's 13F filing for Q1 2026, filed 29 Apr 2026.